Axel Bouchon

Dr. Bouchon has served as the chairman of BrainLuxury Inc, a consumer company engaged in the nutritional supplements business in the United States, since January 2021; chairman of Brain Games Corporation, a consumer company engaged in the neurotechnology business in the United States, since January 2020; and Geschäftsführer (chief executive officer) of AMLOne UG (limited liability), an investment and consulting company in Germany, since its founding in July 2016. From January 2015 to June 2019, Dr. Bouchon was at Bayer AG, a company specializing in pharmaceutical, consumer health, and agricultural products listed on the German Stock Exchange (stock code: BAYRY). Dr. Bouchon was the Head of Leaps by Bayer (former Bayer Lifescience Center). Between November 2013 and December 2014, Dr. Bouchon was Serial CEO of Moderna Ventures and a member of the Moderna Therapeutics, Inc. Executive Committee. Moderna Therapeutics, Inc. is a pharmaceutical and biotechnology company listed on the NASDAQ Stock Exchange in the United States (stock code: MRNA). Dr. Bouchon obtained his diploma in Biochemistry, and a Doctor of Natural Sciences from the Eberhard Karls University of Tübingen in Germany in November 1998 and July 2002 respectively.